How to ease bone pain from systemic mastocytosis
Roughly 50% of people with SM have bone involvement.
Roughly 50% of people with SM have bone involvement.
If these symptoms appear suddenly, call emergency services.
Symptom diary is typically excellent at inducing memory recall in tracking disease evolution in SM.
Outcomes among patients with mast cell leukemia remain relatively poor.
18% of people with mastocytosis also have HαT.
A new study explores the diagnostic challenges posed by SM with an associated myeloid neoplasm (SM-AMN), an advanced form of SM.
Midostaurin is safe and effective in treating advanced systemic mastocytosis.
Depression is a mental health issue that should be taken seriously, as it can worsen over time if left untreated.
Midostaurin can be an effective therapy in the management of aggressive systemic mastocytosis.
From treatments to lifestyle changes, new patients will need answers to many aspects of living with SM.